Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 3 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

BENZODIAZEPINES AS SOLE TREATMENT vs placebo

Adverse effects (drop‐outs due to adverse effects4) · patients with schizophrenia

1 finding from 1 review

Benzodiazepines for schizophrenia 2012 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 161 participants
Very low

ADJUNCTIVE BENZODIAZEPINES + ANTIPSYCHOTICS vs placebo/no adjunctive treatment + antipsychotics

Adverse effects (drop‐outs due to adverse effects4) · patients with schizophrenia

It is very uncertain whether ADJUNCTIVE BENZODIAZEPINES + ANTIPSYCHOTICS changes leaving the study early due to adverse effects (overall tolerability… compared with PLACEBO/NO ADJUNCTIVE TREATMENT + ANTIPSYCHOTICS (very low certainty).

1 finding from 1 review

Benzodiazepines for schizophrenia 2012 · Cochrane Headline outcomes only
RR 3.24 [0.68, 15.45]
6 studies · 415 participants
Very low

Benzodiazepines vs antipsychotics

Adverse effects (drop‐outs due to adverse effects4) · patients with schizophrenia

It is very uncertain whether BENZODIAZEPINES changes leaving the study early due to adverse effects (overall tolerability… compared with ANTIPSYCHOTICS (very low certainty).

1 finding from 1 review

Benzodiazepines for schizophrenia 2012 · Cochrane Headline outcomes only
RR 13 [0.78, 216.39]
5 studies · 444 participants
Very low